Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
Conditions:   Coronary Artery Disease;   ECG Abnormalities From Contrast Agents Interventions:   Drug: Iodixanol;   Drug: Iohexol Sponsor:   Minneapolis Heart Institute Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 1, 2021 Category: Research Source Type: clinical trials